ANI Pharmaceuticals Inc (ANIP): Operating Income
$111.09M
Year ended 2025-12-31
$150.35M
Trailing 12 months to 2026-06-30
+13.0%
10-year compound annual growth
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $111.09M | n/m | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $584.0K | -98.8% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $46.97M | n/m | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | -$35.28M | n/m | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | -$39.79M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$16.02M | n/m | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $16.35M | -53.8% | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $35.36M | +24.8% | 2021-03-11, From 2018-01-01 |
| 2017-12-31 | $28.33M | +41.1% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $20.08M | -38.6% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $32.70M | +63.5% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $20.01M | n/m | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $898.0K | n/m | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | -$42.0K | n/a | 2014-02-28, From 2012-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $111.09M | n/m |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $208.47M | +9.2% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $98.35M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$381.68M | n/m |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$300.10M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $179.64M | +5.7% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $44.80M | -67.3% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $100.10M | n/m |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $104.81M | -54.6% |
Compare ANIP, HRMY, ARWR, IONS side by side · Screen every company in Pharmaceutical Preparations ↗